Iveric Bio, Inc.
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Ophthotech Corporation (to 2019)
0
Ending by 2030
none
Next term end
When these terms end
Held patents by the year their term ends
2026 · 0 end2027 · 02028 · 02029 · 02030 · 0
Fee deadlines
No maintenance fee falls due on this company's record before Nov 22, 2027.
Recent changes
- 1 term has ended since Aug 24, 2026
- Nov 11 US 8,236,773 Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders · term ended
Patents held now
No patent on this record is in force and held under this name now.
Also on record: 4 patents in force now held by others · 8 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 7 abandoned
Showing 1 to 8 of 8, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/132,332 | ANTI-C5 Agent for Treatment of Dry Age-Related Macular Degeneration (AMD) or Geographic Atrophy Secondary to Dry Amd | Apr 7, 2023 | Abandoned |
| 18/132,315 | ANTI-C5 Agent for Treatment of Dry Age-Related Macular Degeneration (AMD) or Geographic Atrophy Secondary to Dry Amd | Apr 7, 2023 | Abandoned |
| 18/132,253 | Methods for Treating or Preventing Ophthalmological Conditions | Apr 7, 2023 | Abandoned |
| 18/107,251 | Method for Treating or Preventing Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) | Feb 8, 2023 | Abandoned |
| 17/958,710 | Methods for Treating or Preventing Ophthalmological Conditions | Oct 3, 2022 | Abandoned |
| 18/034,821 | Methods for Treating Ophthalmological Conditions | Oct 31, 2021 | Pending |
| 17/772,291 | ANTI-C5 Agent for Treatment of Dry Age-Related Macular Degeneration (AMD) or Geographic Atrophy Secondary to Dry Amd | Oct 26, 2020 | Abandoned |
| 16/434,018 | Methods for Treating or Preventing Ophthalmological Conditions | Jun 6, 2019 | Abandoned |